Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
US8388963B2 · kind B2 · utility
7Cited by
1References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 24, 2009 |
| Grant date | Mar 5, 2013 |
| Priority date | — |
| Expiry date | Jul 24, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to antitumor combinations comprising a VEGF inhibitor combined with 5-fluorouracil or with a 5-fluoropyrimidine derivative that are therapeutically useful in the treatment of neoplastic diseases, and pharmaceutical compositions comprising such combinations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.